LISBETH SOLER DE MARCO: Open Payments
NPI 1255189163 · LAKE WORTH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,808 in 63 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $463 · 2025 $1,808
Food & beverage: $1,808
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $518 |
| Madrigal Pharmaceuticals | 7 | $315 |
| Janssen Biotech, Inc. | 5 | $235 |
| Novo Nordisk Inc | 3 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $136 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $114 |
| Ardelyx, Inc. | 4 | $103 |
| Braintree Laboratories, Inc. | 2 | $62 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $38 |
Products named: REZDIFFRA, TREMFYA, Wegovy, CREON, RINVOQ, XIFAXAN, IBSRELA, LINZESS.
Industry payments across FL — which companies pay providers there.
